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Aim—The broad objective of this study was to examine multiple dimensions of depression in a 
large, diverse population of adults with diabetes. Specific aims were to measure the association of 
depression with: (1) patient characteristics; (2) outcomes; and (3) diabetes-related quality of care.
Methods—Cross-sectional analyses were performed using survey and chart data from the 
Translating Research Into Action for Diabetes (TRIAD) study, including 8790 adults with 
diabetes, enrolled in 10 managed care health plans in 7 states. Depression was measured using the 
Patient Health Questionnaire (PHQ-8). Patient characteristics, outcomes and quality of care were 
measured using validated survey items and chart data.
Results—Nearly 18% of patients had major depression, with prevalence 2-3 times higher among 
patients with low socioeconomic status. Pain and limited mobility were strongly associated with 
depression, controlling for other patient characteristics. Depression was associated with slightly 
worse glycemic control, but not other intermediate clinical outcomes. Depressed patients received 
slightly fewer recommended diabetes-related processes of care.
Conclusions—In a large, diverse cohort of patients with diabetes, depression was most 
prevalent among patients with low socioeconomic status and those with pain, and was associated 
with slightly worse glycemic control and quality of care.
1. Introduction
Depression is a common co-morbid condition among adults with diabetes with prevalence 
estimates ranging from 8.3% to over 30% – as much as three times higher than in non-
diabetic populations [1–5]. Depression has been associated with worse diabetes-related 
outcomes including poorer glycemic control, other cardiovascular disease risk factors, a 
greater diabetes symptom burden and poorer quality of life [6–9]. Patients with diabetes and 
co-morbid depression have been found to be at an increased risk of death from all causes, 
including those unrelated to diabetes [10–12]. Depression has been associated with 
suboptimal self-care and poor treatment adherence, thus contributing to adverse outcomes 
[13–16]. Co-morbid depression also results in higher utilization for both medical and mental 
health care, and higher health care costs [15,17,18]. Furthermore, previous studies have 
shown that co-morbid depression may often be unrecognized and untreated in individuals 
with diabetes [19–21]. With emerging evidence that depression treatment improves patient 
outcomes [22–25], it is important to clarify which diabetes patients are at risk for 
depression, and the relationships between depression, quality of care and outcomes for 
diabetes.
Estimates of the prevalence of co-morbid depression with diabetes vary widely. A number 
of methodological factors affecting these estimates have been identified, including 
differences in depression measures, population size and characteristics, study design and the 
inclusion of confounding variables [1,2,26]. These methodological issues are further 
compounded in studies of outcomes associated with co-morbid depression. Health systems 
factors can directly and indirectly affect quality of care for diabetes, depression and 
associated outcomes [27–29], but have received very little attention. Few previous diabetes 
studies have been designed to include sufficient diversity in patient characteristics and 
health system factors, as well as an adequate sample size, to assess the independent 
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association of a broad range of patient characteristics and outcomes associated with 
depression.
The Translating Research Into Action for Diabetes (TRIAD) study, with nearly 12,000 
diabetes patients varying in age, race/ethnicity and socioeconomic position, receiving care 
under many different health care plans across the U.S., offers the opportunity to better 
elucidate the relationships of depression with patient characteristics, quality, and outcomes. 
The three specific aims of this diabetes study were to measure the association of co-morbid 
depression with: (1) patient characteristics; (2) outcomes; and (3) diabetes-related quality of 
care.
2. Methods
The main objective of the TRIAD study was to measure quality of care and outcomes among 
a diverse population of people with diabetes receiving care under varying managed health 
care systems located throughout the U.S. The TRIAD study design, key hypotheses and 
sampling frame have been described elsewhere [30]. Six centers (Pacific Health Research 
Institute, Hawaii; University of California, Los Angeles; Kaiser Permanente Northern 
California; University of Michigan; Indiana University; and the University of Medicine and 
Dentistry of New Jersey) partnered with ten managed care plans in seven states for this 
study. A standard algorithm was used to identify all adult (age 18 and older) patients with 
diabetes in each health plan with continuous enrollment for at least 18 months. Patients were 
randomly selected within each health plan and recruited to participate in a computer assisted 
telephone interview (CATI) or mailed survey. The surveys included measures of a broad 
range of domains, including socio-demographic information, measures of quality of care, 
self-care, mental and physical health and quality of life. Surveys were conducted in English 
and Spanish. Medical records were reviewed to collect information on medications, lab 
results and co-morbid conditions. We excluded patients who denied having diabetes; were 
pregnant at the time of the survey; lived in a non-community setting; did not use the health 
plan for the majority of their diabetes care; or were unable to give informed consent. The 
study protocol was reviewed and approved by all relevant Institutional Review Boards.
A follow-up patient survey was conducted between July 2002 and June 2003, 18 months 
after the baseline survey, among all surviving members of the baseline survey cohort. A 
total of 8790 (74%) patients completed this survey and medical records were reviewed for 
6072 (69%). Results reported in this paper use data from the follow-up survey, 
corresponding chart review data and baseline demographics.
2.1. Measures
Depression was measured using the 8-item version of the Patient Health Questionnaire 
(PHQ)[31]. The PHQ is based on DSM-IV criteria and has a sensitivity of 88% and a 
specificity of 88% for major depression (PHQ score ≥10) in comparison to interviews by 
mental health professionals. The PHQ-8 excludes the suicidality item of the PHQ-9, making 
it a more appropriate instrument to use for survey research, while still retaining the 
psychometric properties of the original instrument as a brief and valid measurement of 
depression [31].
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We used validated cut points indicating levels of depression (minimal to none [PHQ score 
0–4], mild [PHQ score 5–9], moderate [PHQ score 10–14], moderate-severe [PHQ score 
15–19] and severe [PHQ score >19])[31]. The Charlson Index was calculated from co-
morbid conditions recorded in the medical record [32]. A diabetes symptom score was 
calculated using eight questions about the frequency of hyperglycemic symptoms, with a 
score range of 8 (low) to 40 (high)[33]. Pain was measured by the single item pain measure 
of the EQ-5D [34], and a single item rating of the quality of diabetes care received (scale of 
1–5, with 1=excellent and 5=poor), were included in the follow-up patient survey.
Seven dichotomous quality of care indicators were measured, receipt of a dilated eye 
examination, A1c test, foot examination, proteinuria assessment, lipid profile, advice to take 
aspirin and an influenza vaccine during the prior 12 months, based on American Diabetes 
Association recommendations. Analyses included a composite measure of these seven 
indicators. Evidence of eye examinations, foot examinations and advice to take aspirin came 
from survey data and/or chart review data. Evidence of A1c tests and proteinuria 
assessments came from chart review data only. Evidence of influenza vaccines was obtained 
solely from the patient survey.
2.2. Analytic approach
The prevalence of depression was measured for the overall TRIAD study population and for 
patient subgroups using a validated PHQ cut point of ≥10, indicating major depression [31] 
without adjusting for other variables.
Regression models were then developed to measure the association of depression using the 
PHQ score as a continuous variable, with key variables within each of the four areas of 
interest: patient characteristics; outcomes (intermediate clinical outcomes and other 
outcomes of interest); quality of care; and self-care behavior. In the first model, a series of 
patient characteristics, including demographic variables, BMI, pain, mobility, diabetes 
treatment, Charlson index, and diabetes duration, were treated as predictors of depression 
(PHQ score) in a single multiple regression model.
In subsequent regression models predicting outcomes, quality of care and self-care 
behaviors; depression (PHQ score) was treated as the main independent variable, with 
adjustment for selected patient characteristics – age, sex, education, income, race/ethnicity, 
diabetes treatment and co-morbid conditions. Individual regression models were then used 
to calculate predicted means (least square means) for each of the four intermediate clinical 
outcomes (A1c, systolic blood pressure, diastolic blood pressure, and LDL), three other 
outcomes of interest (diabetes symptom score, outpatient visits during the prior year, and 
rating of diabetes care quality), two measures of self-care behavior (percentage of non-
smokers and self-monitoring of blood glucose (SMBG)) and each of the seven quality of 
care measures, individually and as a summary measure, by severity of depression (category 
of PHQ score).
Hierarchical random effects models were used to account for clustering of patients within 
health plans and provider groups. The model for the diabetes symptom score was 
additionally adjusted for most recent A1c value, and models for quality of care measures 
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were additionally adjusted for number of outpatient visits in the prior year. The model for 
SMBG included only patients using insulin.
Dichotomous outcomes (quality of care indicators), were modeled using logistic regression, 
and continuous outcomes (intermediate clinical outcomes), were modeled using linear 
regression. Predicted values included in the tables are predicted marginal mean values. 
Analyses were performed using the General Linear Model for Mixture Distributions (GLIM-
MIX) procedure in SAS V9.1. Missing data were imputed using Imputation and Variance 
Estimation Software (IVEware) and results were based on five imputations. Synthesis of the 
multiple imputation results was performed using the “MIAnalyze” procedure in SAS 
[35,36].
3. Results
3.1. Sample characteristics
The mean age of the 8790 TRIAD study follow-up participants was 61.8 years, 53% were 
female, and more than 90% had type 2 diabetes. Mean duration of diabetes was 13.5 years. 
Among study participants, 44% were white, non-Hispanic, 16% were Asian/Pacific Islander, 
16% were Hispanic, 15% were African American and 9% belonged to other racial or ethnic 
groups.
3.2. Prevalence of depression and patient characteristics
3.2.1. Unadjusted results—Unadjusted results showed an overall rate of major 
depression (PHQ score >10) of 18% (Table 1). Depression rates were highest among 
women, younger patients, those with lower socioeconomic status and patients who reported 
experiencing pain.
Nearly 21% of women met the criteria for major depression, compared to 14% of men. 
Younger patients (age 18–44 years) had the highest rate of major depression (22%), 
compared to those ages 45–64 years (21%) and those age 65 years and older (14%). The 
prevalenceof major depression was highest among African American patients (24%) and 
lowest among Asian/Pacific Islander patients (12%), with rates of 19% and 18% for 
Hispanic participants and white, non-Hispanic participants respectively.
Socioeconomic status indicators were strongly associated with the unadjusted prevalence of 
major depression. The rate of major depression was more than three times higher among 
participants earning less than $15,000 annually (29%), compared with those earning more 
than $75,000 (9%). Similarly, the rate of major depression was 14% among those with more 
than a high school education, compared to 26% among those who did not complete high 
school. Nearly half of participants who reported being unemployed due to health reasons or 
other reasons had major depression (48% and 33% respectively).
Pain and limited mobility had the greatest impact on depression scores of all the patient 
characteristics studied. Nearly half (49%) of the participants who reported having extreme 
pain met the criteria for major depression, compared to 8% of participants who reported 
having no pain. Similarly, 44% of the participants who reported being bedridden met the 
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criteria for major depression, compared to 10% of those who reported having no trouble 
walking.
3.2.2. Results of multivariate models—Combining all patient characteristics into a 
single multivariate model enabled us to measure the independent association of each 
characteristic with depression (PHQ score). Results of this model (Table 1) showed that 
most patient characteristics remained independently and significantly associated with 
depression (P<.05). Exceptions included race/ethnicity, which was no longer significantly 
associated with depression after controlling for other patient characteristics (P = .079). 
Diabetes treatment (P = .079), other co-morbid conditions (P = .119) and diabetes duration 
(P =.230) were also not significantly associated with depression in this multivariate model 
(Table 1).
Socioeconomic status indicators remained strongly associated with depression in 
multivariate results. Individuals reporting an annual income of less than $15,000 had a mean 
PHQ score of 5.9, compared to a mean score of 4.3 among participants with an annual 
income greater than $75,000 (P<.0001). Similarly, patients reporting the lowest education 
had the highest mean PHQ score (5.7 for patients who did not complete high school 
compared to 4.9 among those with more than a high school education, P<.0001). Patients 
who were unemployed, particularly for health reasons, had a higher mean PHQ score (7.1 
compared to 4.8 for those employed by others).
Controlling for all other variables in the model, we found that self-reported pain had the 
greatest impact on PHQ score. Participants reporting extreme pain had a predicted mean 
PHQ score of 7.9 compared to 4.2 for those reporting no pain. Results for limited mobility 
were similar.
3.3. Outcomes
Results of adjusted models did not show a strong association between depression and 
intermediate clinical outcomes (Table 2). The mean A1c value was 7.9 for patients with 
severe depression, compared to 7.7 for those with minimal or no depression (P<.02). 
Depression was not significantly associated with blood pressure or LDL levels.
We did observe strong associations between the severity of depression and other diabetes 
outcomes (Table 2). The adjusted mean diabetes symptom score was 14.6 among patients 
with minimal or no depression compared to 21.6 among patients with severe depression (P<.
0001). Outpatient visits during the prior year increased with PHQ score, with 5.8 visits 
among patients with minimal or no depression compared to 6.9 among those with severe 
depression (P< .002). Patients with severe depression also rated the quality of their diabetes 
care lower with a mean adjusted score of 2.5 in a range of 1 (excellent) to 5 (poor), 
compared to 2.0 among those with minimal or no depression (P<.0001).
3.4. Quality of care and self-care
The adjusted summary measure of diabetes-related quality of care indicated that patients 
with depression received slightly fewer of the seven recommended processes of care (Table 
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3). Patients with severe depression received 5.1 services on average, compared to 5.3 among 
patients with minimal or no depression (P < .001).
Patients with depression received significantly fewer (P <.02) dilated eye examinations, A1c 
tests, and foot examinations in particular (90% among patients with minimal or no 
depression compared to 84% among those with severe depression). The lowest rates of eye 
examinations and A1c testing were among patients with moderate depression, and not 
among patients with severe depression. Patients with severe depression also received fewer 
proteinuria and lipid assessments, and influenza vaccinations, although not to a statistically 
significant degree.
Eighty-nine percent of patients with minimal or no depression were current non-smokers 
compared to 80%of those with severe depression (P < .0001). Rates of SMBG were not 
associated with depression severity.
4. Discussion
4.1. Depression prevalence and important correlates
Methodological issues associated with previous studies have resulted in large differences in 
estimates of co-morbid depression prevalence rates, as well as conflicting results about the 
impact of depression upon outcomes. The most frequently identified issues are limited 
sample size, the use of different measures of depression, the lack of a control group, and the 
failure to adequately include important confounding variables [1,26]. Health system factors 
in particular have received very little attention for their potential direct and indirect effects 
upon diabetes and depression treatment, quality of care and outcomes. The impact of these 
potentially confounding factors, such as benefit structure, co-pay amounts, requirements for 
pre-approval of specialist care, and the use of electronic medical record systems [27–
29,37,38] are difficult to take into consideration in studies of single health care plans.
The use of meta-analysis has overcome some of these methodological issues [1,26]. 
However, meta-analyses are limited in the assessment of important confounding variables. 
For example, a number of studies have estimated depression prevalence among racial/ethnic 
subgroups with diabetes, but few have controlled for differences in socioeconomic status, 
known to be correlated with depression [39–42]. The study most comparable to ours (Li et. 
al.) used the PHQ-8 with a large, geographically varied community sample [43]. The overall 
prevalence of co-morbid major depression (PHQ ≥ 10) reported by this study was 14.4%, 
somewhat lower than our finding (17.9%), and likely due to study population differences. 
While results from this study report as much as a 25 fold difference in the rates of major 
depression across racial/ethnic groups, we found that after adjusting for income, education 
and other relevant covariates, there were no statistically significant differences in the rates of 
major depression across racial/ethnic groups.
Two other important correlates of depression were identified in our study were pain and 
limited mobility. Pain has been associated with suboptimal self-care [44], particularly a lack 
of exercise, and may negatively affect outcomes.
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4.2. Outcomes
We did not find a strong relationship between intermediate clinical outcomes for diabetes 
and depression. Our study confirmed a link between glycemic control and depression 
[6,45,46], but the difference in adjusted A1c levels between non-depressed and severely 
depressed patients was small.
We found strong associations between depression and health care utilization, rating of 
diabetes care quality, and reported symptoms of hyperglycemia. The finding of poorer 
quality of diabetes care among depressed patients is consistent with previous studies [16,47]. 
This finding is noteworthy since depressed patients saw health care providers more often, 
presenting more opportunities for care, yet they did receive slightly fewer recommended 
diabetes services. Higher health care utilization could be related to clinical complexity and 
physicians may have spent more time discussing depression or related symptoms, leaving 
less time for standard diabetes care.
4.3. Limitations
A limitation of our study is that we did not have a control group of people without diabetes. 
In addition, the results of our study may not be comparable to results measuring depression 
using more in-depth interviews by mental health professionals. Finally, as across-sectional 
study, we cannot describe with confidence the causal pathways among diabetes, depression, 
other patient characteristics, and outcomes.
5. Conclusions
While there are many previous studies of diabetes and co-morbid depression, the results of 
this study are based on the largest and most diverse sample of patients and health care 
systems ever undertaken. The TRIAD study sampling design, and the collection of 
comprehensive covariate data, enabled the independent assessment of a broad range of 
correlates and outcomes associated with depression.
The strong association of socioeconomic status and co-morbid depression was clear. The 
association of race/ethnicity and socioeconomic status may result in findings of higher 
depression rates in minority groups, as shown by the high unadjusted rates of depression we 
found among some groups. However, the more important risk factors were income and 
education, not race/ethnicity, as shown in adjusted analyses. Although minority and low 
income patients may be at higher risk for depression, other studies have reported that these 
patient groups are significantly less likely to be screened and treated for depression 
[20,21,48]. Effective depression treatments are available [22,24,25,49,50], and the 
continuity of health care to optimally manage diabetes presents an opportunity to detect and 
treat depression in populations at risk.
The relationship between depression and pain is complicated, however, recent studies 
suggest that antidepressant medication may reduce the pain experienced by patients with 
diabetes [23,24]. Evidence-based pain management strategies should be considered for 
patients with diabetes, depression and pain.
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Finally, there is increasing evidence that treatment for depression is effective in patients 
with diabetes and may help improve diabetes-related outcomes including mortality, quality 
of life and reduce health care costs [11,22,25,49].
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Table 1
Patient characteristics as predictors of PHQ score and unadjusted percentage of patients with major 
depression.
N=8790 Unadjusted % Major depression (PHQ ≥ 10) Adjusteda mean PHQ score 95% CI
Total 17.9 – –
Sex
 Female (53%) 20.9 5.3 5.1–5.5
 Male (47%) 14.2 5.0 4.8–5.2
Age
 18–44 (10%) 22.2 6.4 6.1–6.8
 45–64 (48%) 20.5 5.6 5.3-5.8
 65+ (42%) 13.7 4.4 4.1-4.6
Education
 <High school grad. (21%) 26.0 5.7 5.5–6.0
 High school grad. (30%) 18.6 5.1 4.9–5.4
 >High school grad. (49%) 14.0 4.9 4.7–5.2
Marital status
 Married (60%) 15.0 5.1 4.9–5.3
 Living as couple (3.0%) 23.2 6.0 5.4–6.6
 Never married (7.6%) 24.7 5.4 5.0–5.9
 Widowed (15.8%) 18.4 4.9 4.6–5.3
 Divorced or separated (13.4%) 24.7 5.2 4.9–5.5
Annual income
 <$15,000 (19%) 29.1 5.9 5.6–6.2
 $15,000–40,000 (37%) 19.7 5.4 5.1–5.7
 $40,000–75,000 (25%) 13.0 4.8 4.6–5.1
 >$75,000 (18%) 8.8 4.3 3.9–4.6
Employment
 Employed by others (35%) 13.8 4.8 4.6–5.1
 Self-employed (7%) 12.0 4.9 4.5–5.4
 Retired (40%) 14.6 4.9 4.7–5.2
 Homemaker (6%) 20.2 5.2 4.7–5.6
 Student (<1%) 25.6 5.8 3.6–8.1
 Unempl. – health (8%) 48.3 7.1 6.7–7.5
 Unempl. – other (3%) 33.4 6.6 5.9–7.2
BMI
 <25 (16%) 14.7 5.2 4.9–5.5
 ≥25 and <30 (32%) 13.0 4.9 4.6–5.1
 ≥30 (52%) 21.7 5.3 5.1–5.5
Pain
 None (39%) 8.4 4.2 3.9–4.4
 Moderate (54%) 20.5 5.5 5.3–5.7
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N=8790 Unadjusted % Major depression (PHQ ≥ 10) Adjusteda mean PHQ score 95% CI
 Extreme (7%) 49.2 7.9 7.5–8.4
Mobility
 No prob. walking (56%) 9.6 4.3 4.1–4.6
 Some prob. walking (44%) 28.1 6.1 5.9–6.4
 Bedridden (<1%) 44.4 7.5 6.1–8.9
a
Results from multivariate model including all variables shown plus co-morbidity, diabetes treatment, race/ethnicity and diabetes duration (non-
significant) with adjustment for clustering within health plans and provider groups.
All variables shown in the table were significant in this model at P < .01, except marital status (P < .05).
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